Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
04/2012
04/11/2012CN102414178A Metal complex having aromatic ligand that contains nitrogen atom
04/11/2012CN102408429A Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase
04/11/2012CN102408427A 莫西沙星中间体〔1s,6r〕—8—苄基—7,9—二氧—2,8—二氮杂双环[4.3.0]壬烷的制备方法 Moxifloxacin intermediate [1s, 6r] -8-benzyl-7,9-dioxo-2,8-diazabicyclo [4.3.0] nonane prepared
04/11/2012CN102408426A Substituted aromatic urea compound and application as anticancer medicament thereof
04/11/2012CN102408425A 用于抑制血管生成的咔啉衍生物及其应用 For inhibiting angiogenesis carboline derivatives and their Applications
04/10/2012US8153796 Tricyclic N-heteroaryl-carboxamide derivatives, preparation and therapeutic use thereof
04/10/2012US8153673 Metalloproteinase inhibitors
04/10/2012US8153652 Fab I inhibitors
04/10/2012US8153651 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
04/10/2012US8153647 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
04/10/2012CA2634646C Pyrimidine derivatives for the treatment of abnormal cell growth
04/10/2012CA2549147C Tricyclic 1-((3-indol-3-yl)carbonyl) piperazine derivatives as cannabinoid cb1 receptor agonists
04/10/2012CA2486308C Hepatitis c virus inhibitors
04/10/2012CA2373159C Cucurbiturils and method for synthesis
04/05/2012WO2012044043A2 Novel method of preparing benzoimidazole derivatives
04/05/2012WO2012043638A1 (aza)indolizine derivative and pharmaceutical use thereof
04/05/2012WO2012042915A1 Sulfamoyl benzoic acid heterobicyclic derivatives as trpm8 antagonists
04/05/2012WO2012042433A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS
04/05/2012WO2012042368A1 Process for preparation of paliperidone
04/05/2012WO2012041814A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
04/05/2012WO2012041789A1 Herbicidal benzoxazinones
04/05/2012WO2012041524A1 Hydrazonopyrazolones as protein tyrosine phosphatase inhibitors
04/05/2012WO2012041227A1 Tetracyclic heterocycle compounds for treating hepatitis c viral infection
04/05/2012WO2012041158A1 Tricyclic compound, preparation method and pharmaceutical use thereof
04/05/2012WO2012041014A1 Tetracyclic indole derivatives for treating hepatitis c virus infection
04/05/2012WO2011143444A3 Diphenylbutypiperidine autophagy inducers
04/05/2012US20120083499 Novel benzenesulfonamides as calcium channel blockers
04/05/2012US20120083488 Tetracyclic compound
04/05/2012US20120083476 Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
04/05/2012US20120082635 2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent dpp-iv inhibitors
04/05/2012CA2812910A1 Method of preparing benzoimidazole derivatives
04/05/2012CA2811773A1 (aza)indolizine derivative and pharmaceutical use thereof
04/05/2012CA2811662A1 Tetracyclic indole derivatives for treating hepatitis c virus infection
04/05/2012CA2811033A1 N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
04/05/2012CA2810954A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
04/04/2012EP2437326A2 Organic electroluminescent element, display device and lighting device
04/04/2012EP2436687A1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
04/04/2012EP2435464A1 Cross-linking reagents for molecular interactions analysis
04/04/2012EP2435437A1 Processes for the preparation of substituted tetrahydro beta-carbolines
04/04/2012EP2435436A1 Pyrimidine inhibitors of kinase activity
04/04/2012EP2435435A1 Pyrimidine inhibitors of kinase activity
04/04/2012EP2435434A1 Heterocyclic urea derivatives and methods of use thereof
04/04/2012EP2435433A1 (dihydro) imidazoiso (5, 1-a) quinolines as fsh receptor agonists for the treatment of fertility disorders
04/04/2012EP2435432A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
04/04/2012EP2435426A1 BENZOXAZEPINES AS INHIBITORS OF PI3K/m TOR AND METHODS OF THEIR USE AND MANUFACTURE
04/04/2012EP2435404A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
04/04/2012EP2435046A1 Heterocyclic compounds for the treatment of stress-related conditions
04/04/2012EP2434891A1 Methods for treating cancer and non-neoplastic conditions
04/04/2012EP2434885A1 Alkoxy tetrahydro-pyridopyrimidine pde10 inhibitors
04/04/2012EP2280959B1 4-amino-indazoles
04/04/2012EP1990343B1 Azaindoles
04/04/2012EP1565452B1 3-substituted-6-aryl pyridines as ligands of c5a receptors
04/04/2012EP1316316B1 Preparations for oral administration
04/04/2012CN102405221A 由二环氨基甲酸酯化合物制备2-氮杂金刚烷化合物的方法 The method of preparation of 2-aza-adamantane compound from bicyclic carbamate compound
04/04/2012CN102399222A 没食子酸苦参碱盐及其制剂的制备方法和用途 Gallic acid salts and preparations MATRINE preparation and use
04/04/2012CN102399221A 双吲哚喹唑啉类生物碱在制备抗肿瘤、抗真菌药物中的应用 Diindolo quinazoline alkaloids in the preparation of anti-tumor, antifungal Application
04/04/2012CN102399220A 三并环类PI3K和mTOR双重抑制剂 Three and ring type PI3K and mTOR dual inhibitors
04/04/2012CN102399219A 一种盐酸莫西沙星中间体的制备方法 A process for preparing intermediates of moxifloxacin hydrochloride
04/04/2012CN102399218A 一类并合三杂环及其作为pi3k抑制剂的用途 A class of merging three heterocyclic inhibitors and their use as pi3k
04/03/2012US8148540 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
04/03/2012US8148530 Process for the preparation of 3.7-diazabicyclo[3.3.1] nonane compounds
04/03/2012US8148529 Pyrrolo[3,2-C] pyridine derivatives and processes for the preparation thereof
04/03/2012US8148527 Resolution of 1-(4-methoxybenzyl)-octahydro-isoquinoline
04/03/2012US8148490 Method of making a cyclic guanidine from a guanidinium salt and a weak acid and coating compositions containing the same
04/03/2012US8148395 Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
04/03/2012US8148394 Azaindoles having serotonin receptor affinity
04/03/2012US8148392 2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use in the treatment of cancer
04/03/2012US8148390 Monocyclic anilide spirolactam CGRP receptor antagonists
04/03/2012US8148388 2,4 (4,6) pyrimidine derivatives
04/03/2012US8148369 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
04/03/2012US8148361 Kinase inhibitors
04/03/2012CA2613015C Pyrrolo [2, 3-b] pyridine derivatives as protein kinase inhibitors
04/03/2012CA2505427C Bicyclic-substituted amines as histamine-3 receptor ligands
03/2012
03/29/2012WO2012040404A1 Monohydrate of an azaadamantane derivative
03/29/2012WO2012039561A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/29/2012WO2012039508A1 Pyrrolopyridine compound and use thereof
03/29/2012WO2012039474A1 Calcium salt of pyrroloquinoline quinone
03/29/2012WO2012039414A1 Substituted polycyclic carbamoyl pyridone derivative prodrug
03/29/2012WO2012039371A1 Cyclopropane compound
03/29/2012WO2012038850A1 Pyridmidones for treatment of potassium channel related diseases
03/29/2012WO2012038743A1 Pyrazolopyridines as inhibitors of the kinase lrrk2
03/29/2012WO2012038521A1 Novel microbiocides
03/29/2012WO2012038081A1 Substituted benzamide compounds
03/29/2012WO2012037782A1 Tricyclic compounds, preparation methods, and their uses
03/29/2012WO2011150205A3 Highly selective asymmetric hydroformylation of (1s,4r) or (1r,4s)-2-azabicyclo[2.2.1]hept-5-en-3- one (+) or (-)-lactam
03/29/2012WO2011060877A3 Materials for organic light emitting devices
03/29/2012US20120077979 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors
03/29/2012US20120077840 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
03/29/2012US20120077830 Caspase inhibitors and uses thereof
03/29/2012US20120077826 [6,5] - bicyclic gpr119 g protein-coupled receptor agonists
03/29/2012US20120077815 Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors
03/29/2012US20120077811 Prodrug forms of kinase inhibitors and their use in therapy
03/29/2012US20120077801 Chemical Compounds 637
03/29/2012US20120077795 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/29/2012US20120077787 Organic compounds
03/29/2012DE102010046412A1 Metall-Ligand Koordinationsverbindungen Metal-ligand coordination compounds
03/29/2012CA2812363A1 Substituted polycyclic carbamoyl pyridone derivative prodrug
03/29/2012CA2811895A1 Cyclopropane compounds
03/29/2012CA2811796A1 Substituted benzamide compounds
03/29/2012CA2809675A1 Monohydrate of an azaadamantane derivative